Microdosing GLP-1s Is Now A Growing Trend
Microdosing GLP-1s: Benefits, Risks, and the Future of Low-Dose GLP-1 Therapy
The landscape of GLP-1 receptor agonists is shifting, and not just for obesity or diabetes. A new trend is emerging—microdosing these powerful drugs. Patients and some physicians are exploring lower-than-recommended doses to manage weight, improve metabolic health, reduce inflammation, and lower costs. But is this approach safe and effective?
